Malirid-DS 7 Tablets

babies: it is not applicable. lactating mother: it is unsafe to use during breastfeeding.
before taking this medication, consult your doctor. pregnancy: it is unsafe to use during pregnancy.
before taking this medication, consult your doctor. driving: this medication may decrease alertness, affect your vision or make you feel sleepy and dizzy so, do not drive if these symptoms occur.
alcohol: it is unsafe to consume alcohol with primaquine phosphate tablets. kidney: consult your doctor before taking this primaquine phosphate tablet.
liver: consult your doctor before taking this primaquine phosphate tablet..

Rash Vomiting Headache Hives Stomach pain Nausea Abdominal pain Itching Heartburn Gastrointestinal discomfort Upper abdominal pain.

MALIRID DS tablet is an anti-parasitic medicine used for the prevention and treatment of malaria. it works by increasing the levels of haeme in the blood, a substance toxic to the malarial parasite, and it kills the parasite & stops the infection from spreading..

If you miss a dose of MALIRID DS, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• MALIRID DS tablet is an anti-parasitic medicine used for the prevention and treatment of malaria. • take MALIRID DS tablet orally with food but try to have it at a fixed time regularly.
• do not skip any doses and finish the entire course of treatment even if you feel better. stopping this medication too early may cause serious side effects.
• this medication may decrease alertness, affect your vision or make you feel sleepy and dizzy so, do not drive if these symptoms occur. • use insect repellent creams or sprays on parts of your body not covered by clothing.
• wear light-coloured and covered clothing when you are outside after sunset..

contraindicated • primaquine phosphate + aurothioglucose: concurrent use of these drugs may result in an increased risk of blood dyscrasias. • primaquine phosphate + levomethadyl: concurrent use of these drugs may result in an increased risk of cardiotoxicity. serious • primaquine phosphate + carbamazepine: concurrent use of these drugs may result in decreased carbamazepine activity. monitor closely • primaquine phosphate + lanthanum carbonate: concurrent use of these drugs may result in reduced bioavailability..